Farther Finance Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.7K Sell
988
-2,365
-71% -$200K ﹤0.01% 3034
2026
Q1
$337K Buy
3,353
+2,287
+215% +$298K ﹤0.01% 1671
2025
Q4
$130K Buy
1,066
+504
+90% +$63.2K ﹤0.01% 2184
2025
Q3
$63.1K Buy
562
+281
+100% +$32.9K ﹤0.01% 2315
2025
Q2
$37.7K Buy
281
+83
+42% +$9.11K ﹤0.01% 2286
2025
Q1
$13.5K Sell
198
-52
-21% -$3.58K ﹤0.01% 2592
2024
Q4
$15.6K Sell
250
-235
-48% -$21.9K ﹤0.01% 2192
2024
Q3
$76.2K Buy
485
+316
+187% +$48.7K ﹤0.01% 1435
2024
Q2
$25.4K Buy
169
+28
+20% +$3.36K ﹤0.01% 1700
2024
Q1
$10.4K Buy
141
+125
+781% +$10.3K ﹤0.01% 1753
2023
Q4
$1.26K Buy
+16
New +$965 ﹤0.01% 2633

Other funds holding TMDX

Farther Finance Advisors's TMDX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Transmedics (TMDX) stake by 71% in Q2 2026, selling an estimated $200K and leaving 988 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3034.

Farther Finance Advisors first reported a position in TMDX in Q4 2023 and has held it in 11 quarters since. The position peaked at $337K in Q1 2026. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Farther Finance Advisors held 988 shares of Transmedics worth $65.7K as of Q2 2026.
  • Farther Finance Advisors sold 2,365 Transmedics shares in Q2 2026, an estimated $200K.
  • Transmedics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3034 holding.
  • Farther Finance Advisors first reported a position in Transmedics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Transmedics position peaked at $337K in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.